相关实验视频
Updated: Jun 11, 2025
11:12
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
22.4K
改善帕金森病管理:利用乐沃多巴优化和外科突破
Ritika Sharma1, Avneet Kour2, Hitesh Kumar Dewangan1
1University Institute of Pharma Sciences (UIPS), Chandigarh University NH-95, Chandigarh Ludhiana Highway, Mohali, Punjab, India.
Current drug targets
|October 1, 2024
概括
本综述探讨了帕金森病 (PD),包括其原因,致病机制,如微质症和莱维体,以及遗传因素. 它强调了包括深度大脑刺激 (DBS) 和新兴的神经保护疗法在内的治疗方法,以改善患者的治疗结果.
科学领域:
- 神经学 神经学
- 神经科学是一个神经科学.
- 遗传学 遗传学 是一个
背景情况:
- 帕金森病 (PD) 是一种复杂的神经退行性疾病,受遗传,环境和行为因素的影响.
- 病原性机制包括反应性微质症和勒维体的形成是PD进展的核心.
- 了解多巴胺基细胞中的蛋白质处理和蛋白酶功能对于PD研究至关重要.
研究的目的:
- 为帕金森病提供全面的审查,包括其发病,诊断,治疗和未来的方向.
- 探索PD所涉及的复杂的致病机制和遗传相互作用.
- 讨论当前和新兴的治疗策略,包括手术干预和神经保护药物.
主要方法:
- 文献综述综合了关于帕金森病的当前研究.
- 对基因突变 (例如,UCH-L1,parkin,α-synuclein) 的分析及其在PD中的作用.
- 检查致病机制,如反应性微质症和莱维体形成.
主要成果:
- 遗传突变显著影响多巴胺细胞中的蛋白质处理,导致PD.
- 深度大脑刺激 (DBS) 为严重的PD病例提供了潜在的治疗方法.
- 非运动性症状,如认知障碍和自主功能障碍,会严重影响患者的生活质量.
结论:
- 帕金森病的研究是动态的,具有显著的潜力,精准医学可以彻底改变治疗.
- 新兴疗法侧重于预防α-synuclein聚合和修改疾病进展.
- 解决运动和非运动症状的整体方法对于改善PD患者的生活质量至关重要.
相关概念视频
01:24Parkinson's Disease: Treatment
233
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
233
01:15Parkinson's Disease: Overview
492
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
492
01:28Drug Therapy
39
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
39
01:29Drugs Affecting Neurotransmitter Synthesis
1.3K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.3K
01:30Psychosurgery
47
Psychosurgery, the surgical alteration or permanent removal of brain tissue to alleviate severe psychological conditions, stands as one of the most radical and controversial treatments in the history of mental health care. Its development and application have evolved significantly, marked by dramatic shifts in scientific understanding and ethical perspectives.
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
47